USA - NASDAQ:NRC - US6373722023 - Common Stock
We assign a fundamental rating of 4 out of 10 to NRC. NRC was compared to 100 industry peers in the Health Care Providers & Services industry. NRC scores excellent on profitability, but there are concerns on its financial health. NRC has a expensive valuation and it also scores bad on growth.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.06% | ||
| ROE | 114.31% | ||
| ROIC | 21.73% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.8% | ||
| PM (TTM) | 11.76% | ||
| GM | 62.05% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.31 | ||
| Debt/FCF | 6.89 | ||
| Altman-Z | 2.94 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.53 | ||
| Quick Ratio | 0.53 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.41 | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.34 | ||
| EV/EBITDA | 11.45 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.64% |
13.78
+0.53 (+4%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.64% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.41 | ||
| Fwd PE | N/A | ||
| P/S | 2.28 | ||
| P/FCF | 27.34 | ||
| P/OCF | 12.39 | ||
| P/B | 22.2 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.45 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.06% | ||
| ROE | 114.31% | ||
| ROCE | 28.35% | ||
| ROIC | 21.73% | ||
| ROICexc | 22.24% | ||
| ROICexgc | 73.35% | ||
| OM | 19.8% | ||
| PM (TTM) | 11.76% | ||
| GM | 62.05% | ||
| FCFM | 8.35% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.31 | ||
| Debt/FCF | 6.89 | ||
| Debt/EBITDA | 2.2 | ||
| Cap/Depr | 200.56% | ||
| Cap/Sales | 10.09% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.27% | ||
| Profit Quality | 71.02% | ||
| Current Ratio | 0.53 | ||
| Quick Ratio | 0.53 | ||
| Altman-Z | 2.94 |
ChartMill assigns a fundamental rating of 4 / 10 to NRC.
ChartMill assigns a valuation rating of 3 / 10 to NATIONAL RESEARCH CORP (NRC). This can be considered as Overvalued.
NATIONAL RESEARCH CORP (NRC) has a profitability rating of 8 / 10.
The financial health rating of NATIONAL RESEARCH CORP (NRC) is 3 / 10.
The dividend rating of NATIONAL RESEARCH CORP (NRC) is 5 / 10 and the dividend payout ratio is 67.82%.